Legal & General Group
CRMD icon

Legal & General Group’s CorMedix CRMD Stock Holding History

Legal & General Group’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$460K Buy
58,595
+9,418
+19% +$74.4K ﹤0.01% 2424
2026
Q1 		$334K Sell
49,177
-16,625
-25% -$123K ﹤0.01% 2455
2025
Q4 		$765K Sell
65,802
-152
-0.2% -$1.68K ﹤0.01% 2291
2025
Q3 		$767K Buy
65,954
+3,334
+5% +$40.3K ﹤0.01% 2316
2025
Q2 		$771K Buy
62,620
+9,155
+17% +$101K ﹤0.01% 2315
2025
Q1 		$329K Buy
53,465
+46,861
+710% +$485K ﹤0.01% 2522
2024
Q4 		$53.5K Buy
6,604
+536
+9% +$5.35K ﹤0.01% 2768
2024
Q3 		$49K Sell
6,068
-83
-1% -$449 ﹤0.01% 2795
2024
Q2 		$26.6K Buy
6,151
+231
+4% +$1.17K ﹤0.01% 2912
2024
Q1 		$25.1K Sell
5,920
-256
-4% -$888 ﹤0.01% 2887
2023
Q4 		$23.2K Buy
6,176
+606
+11% +$2.08K ﹤0.01% 2976
2023
Q3 		$20.6K Buy
5,570
+252
+5% +$1K ﹤0.01% 3017
2023
Q2 		$21.1K Buy
+5,318
New +$26.3K ﹤0.01% 3096
2022
Q2 		– Sell
-3,200
Closed -$18K – 3552
2022
Q1 		$18K Hold
3,200
– – ﹤0.01% 3263
2021
Q4 		$15K Hold
3,200
– – ﹤0.01% 3361
2021
Q3 		$15K Sell
3,200
-236
-7% -$1.37K ﹤0.01% 3359
2021
Q2 		$24K Sell
3,436
-284
-8% -$2.26K ﹤0.01% 3225
2021
Q1 		$37K Hold
3,720
– – ﹤0.01% 2919
2020
Q4 		$28K Hold
3,720
– – ﹤0.01% 2964
2020
Q3 		$22K Sell
3,720
-247
-6% -$1.24K ﹤0.01% 2942
2020
Q2 		$25K Hold
3,967
– – ﹤0.01% 2966
2020
Q1 		$14K Sell
3,967
-855
-18% -$4.83K ﹤0.01% 3047
2019
Q4 		$33K Buy
4,822
+887
+23% +$5.42K ﹤0.01% 3001
2019
Q3 		$25K Hold
3,935
– – ﹤0.01% 3054
2019
Q2 		$30K Buy
+3,935
New +$30.9K ﹤0.01% 3015

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Legal & General Group's CRMD Position: Q2 2026 in Review

Legal & General Group increased its CorMedix (CRMD) stake by 19% in Q2 2026, buying an estimated $74.4K and bringing the position to 58,595 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #2424.

Legal & General Group first reported a position in CRMD in Q2 2019 and has held it in 25 quarters since. The position peaked at $771K in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Legal & General Group held 58,595 shares of CorMedix worth $460K as of Q2 2026.
  • Legal & General Group bought 9,418 CorMedix shares in Q2 2026, an estimated $74.4K.
  • CorMedix made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2424 holding.
  • Legal & General Group first reported a position in CorMedix in Q2 2019 and has held it in 25 quarters since.
  • Legal & General Group's CorMedix position peaked at $771K in Q2 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.